1. Assess urgency

2. Essential preoperative work-up

1. Contrast CT abdomen and pelvis, preferably CT angiography
   • Measure the fascial defect width and area.
   • Identify hernia contents, loss of domain, multiple defects, bowel adherence, and prior operative planes.
   • Precisely map the bypass graft, anastomoses, and graft limbs to both groins relative to the planned incision, mesh plane, and any port sites.
   • CT or MRI is recommended for preoperative planning of incisional hernia repair. The European Hernia Society guideline notes that a defect width over 8 cm or area over 164 cm² predicts likely need for a myofascial-release technique.
2. Vascular assessment
   • Vascular surgery review before elective repair.
   • Document distal pulses, ABI if feasible, and duplex/CTA evidence of graft patency.
   • Review the original bypass indication, graft type and route, and operative notes.
   • Clarify the current antithrombotic treatment: aspirin, dual antiplatelet therapy, warfarin, or a DOAC. Any interruption or bridging plan must be individualized by the vascular/anesthesia team. Do not stop these drugs independently.
3. Optimize risk factors
   • Smoking cessation.
   • Improve glycemic control.
   • Weight reduction where feasible.
   • Treat malnutrition, anemia, chest disease/chronic cough, constipation, and urinary obstruction.
   • The EHS identifies high BMI, smoking, and poorly controlled diabetes as key modifiable risks before incisional-hernia surgery (guideline summary).
4. Exclude infection
   • Examine both groins and midline scar for draining sinus, erythema, seroma, or infection.
   • Any suspected graft or wound infection needs vascular-led investigation before elective mesh repair. Permanent synthetic mesh should not be placed in an uncontrolled contaminated or infected field.

3. Likely operative strategy

• Restore midline fascial continuity without excessive tension.
• Reinforce with a large permanent synthetic mesh in a retromuscular/preperitoneal plane, if a clean field and anatomy allow.
• Obtain wide mesh overlap beyond the defect.
• Avoid direct contact between mesh, bowel, and the vascular graft where possible.

Important graft-specific technical principles

• The vascular surgeon should be available or directly involved, especially if CT shows the graft near the operative field.
• Do not dissect blindly in the preperitoneal/retrorectus plane if it contains or approaches a bypass limb.
• Avoid fixation sutures, tacks, or transfascial needles where they could enter the graft.
• Avoid trocar placement or additional groin dissection along the graft limbs.
• Protect the graft from contamination and minimize unnecessary exposure. A graft infection is much more serious than a routine mesh infection.
• If the graft route prevents a safe retromuscular reconstruction, the team may choose an alternative plane or a tailored open/hybrid approach. The choice cannot be made safely without reviewing the CT and original bypass anatomy.

4. Open versus minimally invasive repair

5. Postoperative priorities

• Monitor limb perfusion closely: pulses, limb pain, pallor, coolness, and ABI/Doppler if concern arises.
• Resume antiplatelet/anticoagulation according to the agreed vascular-hemostasis plan.
• Standard VTE prophylaxis, early mobilization, pulmonary physiotherapy, and good analgesia.
• Close surveillance for wound/mesh infection, seroma, bowel injury, and graft-related infection.
• Avoid heavy lifting until the operating surgeon permits it.

Bottom line

• Craniocaudal length: 12.2 cm
• Transverse rectus separation/defect width: 10.3 cm
• Approximate defect area: 126 cm² if roughly rectangular
• Contents: small bowel and omental/properitoneal fat

What to optimize before elective surgery

1. Confirm vascular-graft status and make an antithrombotic plan

• Obtain/review CT angiography with arterial phase, including abdomen and groins, to map the bypass graft and both limbs.
• Vascular-surgery consultation to document graft patency, limb pulses, and need for duplex/ABI.
• Obtain the original bypass operative note if available.
• Review all drugs, especially aspirin, clopidogrel, warfarin, rivaroxaban/apixaban, or cilostazol.
• The vascular surgeon, anesthetist, and hernia surgeon must make a written plan for continuation, temporary interruption, or bridging. A person with a bypass performed for thrombosis must not stop antiplatelet or anticoagulant medication without that plan.

2. Weight and nutrition

• Record BMI, waist circumference, recent weight change, and functional capacity.
• If overweight or obese, aim for realistic, supervised weight reduction without causing malnutrition.
• Check:
  • CBC and iron studies
  • Serum albumin and nutritional assessment
  • Renal and liver profile
  • Vitamin B12/folate if anemia or nutritional concern
• Ensure adequate protein intake. If there has been unintentional weight loss, low albumin, poor appetite, or frailty, involve a dietitian before surgery.

3. Diabetes and glucose

• Check fasting glucose and HbA1c even if diabetes is not already known.
• Optimize diabetic treatment before surgery. Poor glycemic control increases wound infection, mesh infection, and recurrence risk.
• The EHS identifies high BMI, smoking, and poorly controlled diabetes as the main modifiable risks, and recommends weight management, HbA1c-based diabetic control, smoking cessation, and improved pulmonary fitness before repair (EHS midline incisional-hernia guideline).

4. Smoking, tobacco, and alcohol

• Stop cigarettes, bidis, vaping nicotine, and chewing tobacco ideally at least 4 weeks before surgery, preferably longer.
• Offer formal cessation treatment: counseling plus nicotine replacement, varenicline, or bupropion where appropriate.
• Screen for harmful alcohol intake and arrange withdrawal prevention if indicated.

5. Pulmonary preparation

• Treat active chest infection and postpone elective repair until resolved.
• Optimize inhalers and teach incentive spirometry or deep-breathing exercises.
• Start daily walking and breathing exercises if able.
• Treat causes of chronic cough because persistent high intra-abdominal pressure increases recurrence risk.

6. Treat raised intra-abdominal pressure

• Constipation: regular fluid/fiber intake and a stool-softener/laxative plan if needed.
• Urinary obstruction: assess men with lower urinary tract symptoms for prostatic obstruction.
• Chronic cough: diagnose and treat.
• Avoid heavy lifting and repeated straining while awaiting surgery.

7. Medication and infection review

• Review chronic steroids, immunosuppressants, biologics, and chemotherapy with the prescribing specialist.
• Look carefully for infection at the midline scar and groin incisions: redness, drainage, sinus, seroma, fever, or unexplained groin pain.
• Treat dental, skin, urinary, respiratory, or other active infections before placing permanent mesh.
• MRSA screening/decolonization follows local hospital protocol.

8. Fitness and anesthesia assessment

• ECG and targeted cardiac assessment based on symptoms, exercise capacity, vascular disease, and anesthetic assessment.
• Renal function and contrast-risk assessment before CTA.
• Begin a gradual prehabilitation program: daily walking, sit-to-stand/leg strengthening, breathing exercises, protein optimization, and sleep improvement.

Surgical planning implication of these measurements

• Closure of the native fascial edges if safely possible.
• Large mesh reinforcement, generally in a retromuscular/preperitoneal plane when the graft anatomy permits.
• Consideration of posterior component separation/TAR to achieve tension-free fascial closure and adequate mesh overlap.
• Avoidance of blind dissection, sutures, tacks, or mesh fixation near the bypass graft.
• Vascular-surgical availability during surgery if imaging suggests the graft lies close to the planned operative plane.

Seek urgent care now if any of these occur

• Hernia becomes irreducible, suddenly painful, hard, red, or tender
• Vomiting, abdominal distension, inability to pass stool or gas
• Fever, rapid worsening pain, or skin color change over the swelling
• New cold, pale, painful, numb, or weak leg, which could indicate a graft-flow problem

Step-by-step approach

1. Identify exactly what medicine he is taking and why

• Aspirin
• Clopidogrel
• Aspirin + clopidogrel together
• Warfarin
• Apixaban, rivaroxaban, dabigatran, edoxaban
• Therapeutic LMWH/enoxaparin injections
• A combination of antiplatelet plus anticoagulant

• Why the bypass thrombosed initially
• Whether a thrombophilia/hypercoagulable disorder was found
• Whether there have been any recurrent clots, acute limb ischemia, DVT/PE, stroke, or coronary stents
• Current graft patency on duplex or CT angiography
• Kidney function, especially if taking a DOAC

2. Decide his thrombotic risk with the vascular surgeon

• High thrombotic risk: prior recurrent arterial thrombosis, recent acute limb ischemia, threatened graft, poor runoff, known thrombophilia, or a requirement for full anticoagulation.
• Lower risk: stable patent graft with standard long-term single-antiplatelet treatment.

Typical perioperative approach by drug

A practical proposed protocol for the surgical team

2-4 weeks before surgery

1. Vascular-surgery consultation
2. Duplex/CTA confirmation of graft patency and exact graft route
3. Document:
   • Current antithrombotic drug(s)
   • Indication for each
   • Thrombotic-risk category
   • Written stop date, bridging decision, and restart plan
4. CBC, platelet count, PT/INR, aPTT, creatinine/eGFR, liver function, group and cross-match.
5. Ensure no active groin, skin, dental, urinary, or systemic infection before mesh implantation.

Before surgery

• The operation should ideally occur with the vascular team available if the graft is near the dissection field.
• Record bilateral femoral and distal pulses, and ideally ABI/Doppler waveform, as the baseline.
• Use mechanical VTE prophylaxis while full anticoagulation is withheld.
• If the vascular team considers him exceptionally high risk, they may use a carefully timed UFH or LMWH bridging protocol, with the final preoperative dose sufficiently early to allow safe surgery. This is a specialist decision, not automatic.

After surgery

• Recheck leg pulses, foot warmth, motor/sensory status, and Doppler signals regularly.
• Start standard postoperative VTE prophylaxis once surgical hemostasis is secure, if the surgeon considers it safe.
• Resume:
  • Aspirin early, often within 24 hours if there is no active bleeding.
  • Clopidogrel or full anticoagulation only after adequate hemostasis, commonly 48-72 hours after a major abdominal-wall reconstruction, but timing may be earlier or later depending on graft risk, drains, bleeding, and reoperation risk.
• If he cannot take oral medication initially and is judged high arterial-thrombotic risk, the vascular team may choose temporary anticoagulation, usually beginning with a cautious postoperative regimen.

What I would avoid

• Stopping all blood thinners many days before surgery without vascular approval.
• Automatically using full-dose heparin bridging just because a patient has a vascular graft.
• Restarting full-dose anticoagulation immediately after a large mesh/TAR repair before hemostasis is established.
• Failing to document postoperative pulse status and a clear restart date.

Bottom line